MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.

ULCER is a more frequent cause of discomfort and disability than of death — that is, for every patient who dies, a far larger number suffer. Yet approximately 10,000 people die annually in the ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

Tests on patients have been encouraging; their ulcers got better when Dr. Cheney fed them on foods containing vitamin U, but he could not prove that U did the trick. Cabbage, Dr. Cheney found ...

Stress ulcers, erosions of the stomach and duodenum ... Although pooled data of two studies suggested that critically ill pediatric patients may benefit from receiving prophylactic treatment ...

“[…] the results of this study indicate that pioglitazone might be useful in treating refractory skin ulcers, a typical condition that reduces the quality of life ...